publication date: Dec. 9, 2010

In this issue: 

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

Chabner Calls For Audit Of I-ELCAP Data, Full Financial Disclosure.

NSABP Protests NIH Rejection Of P-4 Appeal.

International Cancer Genome Consortium Aims To Produce Data On 50 Cancer Types.

Download (PDF 1.0MB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.